Dr. Sulman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
560 1st Ave
Fl 2
New York, NY 10016Phone+1 646-501-8900Fax+1 646-501-8904
Education & Training
- University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2004 - 2008
- Albert Einstein Medical CenterInternship, Transitional Year, 2003 - 2004
- Lewis Katz School of Medicine at Temple UniversityClass of 2003
Certifications & Licensure
- NY State Medical License 2018 - 2026
- TX State Medical License 2008 - 2025
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 17 citationsInhibition of nonsense-mediated decay rescues p53β/γ isoform expression and activates the p53 pathway in MDM2-overexpressing and select p53-mutant cancers.Jayanthi Gudikote, Tina Cascone, Alissa Poteete, Piyada Sitthideatphaiboon, Qiuyu Wu
The Journal of Biological Chemistry. 2021-11-01 - 884 citationsThe transcriptional network for mesenchymal transformation of brain tumoursMaria Stella Carro, Wei Keat Lim, Mariano J. Alvarez, Robert J. Bollo, Xudong Zhao
Nature. 2010-01-21 - 175 citationsMST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in GlioblastomaTianzhi Huang, Chung Kwon Kim, Angel Alvarez, Rajendra P. Pangeni, Xuechao Wan
Cancer Cell. 2017-12-11
Journal Articles
- BCAT1 and miR-2504: Novel Methylome Signature Distinguishes spindle/desmoplastic Melanoma from Superficial Malignant Peripheral Nerve Sheath TumorErik P Sulman, Matija Snuderl, George Jour, Phyu P Aung, Nature
- A Co-Clinical Radiogenomic Validation Study - Conserved Magnetic Resonance Radiomic Appearance of Periostin Expressing Glioblastoma in Patients and Xenograft ModelsSanjay K Singh, Ashok J Kumar, Rivka R Colen, Gregory N Fuller, Frederick F Lang, Erik P Sulman, Clinical Cancer Research
- Cell Surface Notch Ligand DLL3 Is a Therapeutic Target in Isocitrate Dehydrogenase Mutant GliomaJohn G Golfinos, Daniel P Cahill, Erik P Sulman, David Zagzag, Clinical Cancer Research
Lectures
- Predictive Molecular Biomarkers: Enriching Clinical Trial Populations for Glioblastoma2013 Annual Meeting, Chicago, Illinois, USA
- Predictive Molecular Biomarkers: Enriching Clinical Trial Populations for GlioblastomaAmerican Society of Clinical Oncology, 2013 Annual Meeting, Chicago, Illinois, USA
Press Mentions
- Novocure Announces Strategic Alliance with NYU Grossman School of Medicine for Preclinical and Clinical ResearchOctober 29th, 2020
- NYU Langone Health Launches New Molecular Assay to Identify Patients with Brain TumorsOctober 24th, 2019
- How a Brain Tumor Taught Me to Embrace MyselfDecember 6th, 2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: